Clinical Trial Update: Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating perfenidone in adults with type 2 diabetes and diabetic neuropathy (with diabetic nephropathy) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Diabetic Neuropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Perfenidone

Snippet

Sponsor: Sidrah Lodhi | Conditions: Diabetic Nephropathies, Type 2 Diabetes | Phase 4 | Status: COMPLETED